Naoko Chayahara
Kobe, 6580064, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Co-occurrence of breast cancer and malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.
Journal: International cancer conference journal
Published: September 26, 2024
Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Journal: Frontiers in oncology
Published: December 05, 2020
Relationship between PDGFR expression and the response to pazopanib in intimal sarcoma of the pulmonary artery: A case report.
Journal: Molecular and clinical oncology
Published: May 30, 2020
Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).
Journal: The oncologist
Published: February 01, 2019
A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.
Journal: Future oncology (London, England)
Published: January 15, 2019
Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma.
Journal: Case reports in oncology
Published: September 26, 2018
Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.
Journal: Auris, nasus, larynx
Published: April 08, 2018
Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.
Journal: Oncotarget
Published: August 23, 2017
Last Updated: 09/26/2026